Zucara Therapeutics receives cash injection to advance novel diabetes drug therapy
VANCOUVER and TORONTO, Canada (November 3, 2016) -- Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel long-term therapeutic approach to prevent hypoglycemia...